ULTRAPROCT SUPOZITOARE suppositories medication leaflet

C05AA08 fluocortolone + cincocaine • Cardiovascular system | Agents for treatment of hemorrhoids and anal fissures for topical use | Corticosteroids

The combination of fluocortolone and cinchocaine is used for the local treatment of hemorrhoids, anal fissures, and other inflammatory conditions of the anal area. Fluocortolone reduces inflammation and itching, while cinchocaine acts as a local anesthetic, quickly relieving pain and discomfort.

The medication is applied as a cream, ointment, or suppository, as directed by your doctor. It is important to follow the duration and frequency of treatment to avoid side effects, especially with prolonged use.

Side effects may include local irritation, burning sensation, or allergic reactions. Excessive or long-term use may lead to skin thinning or systemic absorption of the active substances, with possible general side effects.

The combination of fluocortolone and cinchocaine is effective in quickly relieving the symptoms of hemorrhoids and other anal inflammations, but should be used with caution and only as recommended by your doctor.

General data about ULTRAPROCT SUPOZITOARE

Substance: fluocortolone + cincocaine

Date of last drug list: 01-05-2026

Commercial code: W67017001

Pharmaceutical form: suppositories

Quantity: 10

Product type: original

Price: 30.25 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: LEO PHARMA MANUFACTURING ITALY S.R.L. - ITALIA

Holder: KARO PHARMA AB - SUEDIA

Number: 1410/2009/01

Shelf life: 3 years

Pharmaceutical forms available for fluocortolone + cincocaine

Compensation lists for ULTRAPROCT SUPOZITOARE KARO PHARMA AB

C3 - Sublist C - section C3 (children, pregnant women and postpartum women) with 100% discount from the reference price

Price

Copayment

Patient

30.25 RON

30.25 RON

0.00 RON